H. Michael Shepard
2013
In 2013, H. Michael Shepard earned a total compensation of $952.9K as Vice President and Chief Scientific Officer at Halozyme Therapeutics, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $257,088 |
|---|---|
| Option Awards | $179,807 |
| Salary | $321,360 |
| Stock Awards | $176,850 |
| Other | $17,804 |
| Total | $952,909 |
Shepard received $321.4K in salary, accounting for 34% of the total pay in 2013.
Shepard also received $257.1K in non-equity incentive plan, $179.8K in option awards, $176.9K in stock awards and $17.8K in other compensation.
Rankings
In 2013, H. Michael Shepard's compensation ranked 6,855th out of 12,286 executives tracked by ExecPay. In other words, Shepard earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,855 out of 12,286 | 44th |
Division Manufacturing | 2,433 out of 4,612 | 47th |
Major group Chemicals And Allied Products | 735 out of 1,462 | 50th |
Industry group Drugs | 542 out of 1,156 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 86 out of 196 | 56th |
Source: SEC filing on April 7, 2014.
Shepard's colleagues
We found five more compensation records of executives who worked with H. Michael Shepard at Halozyme Therapeutics in 2013.
2013
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
2013
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2013
James Shaffer
Halozyme Therapeutics
Former Vice President and Chief Commercial Officer
2013
Jean Liu
Halozyme Therapeutics
General Counsel
2013
Kurt Gustafson
Halozyme Therapeutics